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ABSTRACT The formation of amyloid and other types of protein ﬁbrils is thought to proceed by a nucleated polymerization
mechanism. One of the most important features commonly associated with nucleated polymerizations is a strong dependence
of the rate on the concentration. However, the dependence of ﬁbril formation rates on concentration can weaken and nearly
disappear as the concentration increases. Using numerical solutions to the rate equations for nucleated polymerization and
analytical solutions to some limiting cases, we examine this phenomenon and show that it is caused by the concentration
approaching and then exceeding the equilibrium constant for dissociation of monomers from species smaller than the nucleus,
a quantity we have named the ‘‘supercritical concentration’’. When the concentration exceeds the supercritical concentration,
the monomer, not the nucleus, is the highest-energy species on the ﬁbril formation pathway, and the ﬁbril formation reaction
behaves initially like an irreversible polymerization. We also derive a relation that can be used in a straightforward method
for determining the nucleus size and the supercritical concentration from experimental measurements of ﬁbril formation rates.
INTRODUCTION
Many diseases, including Alzheimer’s disease, appear to be
caused by the formation and deposition of a ﬁbrillar protein
aggregate known as amyloid (1–4). Amyloidogenic proteins
(5,6), like other ﬁbril-forming proteins (7), have been
suggested to self-assemble by a nucleated polymerization
mechanism. In a nucleated polymerization, the growth of
aggregates occurs by sequential monomer addition (7–9).
Monomer addition is unfavorable for species smaller than a
critical size, but favorable for larger species. This critical size
(n monomer units) deﬁnes the nucleus (Xn), which is the
highest-energy species on the polymerization pathway
(8,10–12).
Nucleated polymerizations have several well-known fea-
tures according to the classical model of Oosawa and
Asakura (7), including 1), a critical concentration, below
which ﬁbrils cannot form; 2), a lag phase before ﬁbrils form,
which can be eliminated by the addition of preformed ﬁbrils
(seeds); and 3), a strong dependence of the ﬁbril formation
rate on concentration, which increases with the size of the
nucleus (7–9). This concentration dependence can be expres-
sed in terms of t50, the time at which a ﬁbril formation reaction
reaches 50% completion, as follows:
logt50 ¼ constant n1 1
2
 
log½X
tot
; (1)
where [X]tot is the total protein concentration, and n is the
number of subunits in the nucleus (see Supplementary
Material). Log-log plots of t50 (or a similar variable) versus
[X]tot are often used in studies of amyloid or other protein
ﬁbril formation reactions (13–17) because their t50 values can
easily be experimentally measured using dye-binding assays
(18–20) or turbidimetry (21). The presence or absence of the
features listed above has been important for interpreting data
from in vitro amyloidogenesis experiments (13–17,22–26),
which, in turn, has been important for formulating hypoth-
eses about the pathogenesis and treatment of amyloid and
other protein aggregation diseases (5,27–31). However, the
classical model of nucleated polymerization cannot hold at
very high concentrations. The stability of the nucleus will in-
crease as the monomer concentration increases, and even-
tually, at high enough concentrations, the nucleus will be
more stable than the monomer (12,32). The concentration at
which this happens will be called the ‘‘supercritical concen-
tration’’. As the supercritical concentration is approached
and then exceeded, the features of a nucleated polymeriza-
tion must become different from those listed above. Here, we
report that the concentration dependence of the rate of a ﬁbril
formation reaction weakens and then nearly disappears as the
concentration increases. We show that the initial weakening
happens because oligomer concentrations become signiﬁcant
at total protein concentrations approaching the supercritical
concentration, but the ﬁbril formation reaction still behaves
in most respects like a classical nucleated polymerization.
Above the supercritical concentration, however, a ﬁbril forma-
tion reaction in its early phases behaves like an irreversible
polymerization, and the rate becomes almost independent of
concentration as a result.
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MATERIALS AND METHODS
Numerical integration of differential equations and other calculations were
performed on a personal computer with dual AMD Athlon 2200 MP
processors using Mathematica 4.2 (Wolfram Research, Champaign, IL) for
Windows XP or Mathematica 5.0 for Linux.
RESULTS
Model
Fig. 1 A is a summary of our model for nucleated poly-
merization. This model contains several assumptions. First,
we assumed that oligomer and ﬁbril sizes can change only by
monomer association or dissociation. Second, we assumed
that the addition of monomers to the nucleus is irreversible
(that is, Xn11 cannot lose a monomer to become Xn, so bn11
¼ 0). This assumption allows us to treat all of the ﬁbrils
together, so that [F] ¼ [Xn11] 1 [Xn12] 1  1 [XN] is the
ﬁbril number concentration and [M]¼ (n1 1)[Xn11]1 (n1
2)[Xn12]1  1 N[XN] is the ﬁbril mass concentration,
where [Xi] is the concentration of an i-mer. The irreversibility
of monomer addition to the nucleus has been justiﬁed by
Ferrone (8) and the division of species into pre- and
postnuclear aggregates (i.e., oligomers and ﬁbrils) has been
used previously in models of nucleated polymerization
(7,8,33–35). Third, we have assumed that all of the as-
sociation rate constants are the same (a1¼ a2¼ a3¼  ¼ aN
¼ a), since they are largely determined by diffusion and
long-range forces (36–38). Finally, we have assumed that all
of the dissociation rate constants for oligomers are the same
(b1 ¼ b2 ¼ b3 ¼  ¼ bn ¼ b), but they decrease sharply for
ﬁbrils and stay constant thereafter (bn12¼ bn13¼  ¼ bN¼
c, b). The decrease in the dissociation rate constant reﬂects
the higher stability of ﬁbrils relative to oligomers. Our third
and fourth assumptions (or similar ones) have been used
previously in models of ﬁbril formation reactions (9,12,39),
but we note that Hill has shown that monomer association
and dissociation constants should both depend continuously
on ﬁbril size (40).
The critical concentration can be deﬁned in terms of the
rate constants as Kc ¼ c/a (7,9,41) and the supercritical
concentration as Ks ¼ b/a. When [X]tot , Kc, all polymers
(ﬁbrils as well as oligomers) are less stable than the
monomer, and ﬁbril formation cannot occur. When Kc ,
[X]tot , Ks, the nucleus is the highest-energy species on the
ﬁbril formation pathway, whereas when Ks , [X]tot, the
monomer is the highest-energy species on the ﬁbril forma-
tion pathway. These points are illustrated in Fig. 1 B. Our
third and fourth assumptions guarantee that the size of the
nucleus will not change as the concentration increases (9).
This feature is most suitable for ﬁbrils with structures in
which there is a sudden change as the ﬁbrils grow in the
number or quality of interactions made. The nucleus is then
determined by the size at which this sudden change occurs.
This structural deﬁnition of the nucleus coincides with the
thermodynamic deﬁnition (i.e., that the nucleus is the
highest-energy species on the polymerization pathway)
when Kc , [X]tot , Ks, but the deﬁnitions diverge when
Ks , [X]tot. At such high protein concentrations, the
thermodynamic nucleus is formally the monomer. Structural
nuclei are likely to be small; it is easy to imagine a stark
difference between the interactions in a tetramer and a
pentamer (as in Fig. 1 B), but not between a 49-mer and a
FIGURE 1 Nucleated polymeriza-
tion mechanism of protein ﬁbril forma-
tion. (A) The sequence of reactions in a
nucleated polymerization. Aggregates
are assumed to grow by monomer
addition. The association and dissocia-
tion rate constants are shown above and
below the arrows, respectively. The rate
constants shown in parentheses arise
from the assumptions in the text. The
n-mer, Xn, is known as the nucleus.
Smaller species are called oligomers,
whereas larger species are called ﬁbrils.
(B) Plots of free energy (relative to the
monomer) versus aggregate size for the
formation of a helical polymer with a
nucleus size of 4. Addition of a mon-
omer to a monomer or an oligomer
creates one new interaction (in the
drawings below the plot, the ovals overlap in one place for X2, X3, and X4). Addition of a monomer to the nucleus or a ﬁbril creates two new interactions
(the ovals overlap in two places for X5 and all larger species). Plots are shown for total protein concentrations i), below the critical concentration; ii), between
the critical and supercritical concentrations; or iii), above the supercritical concentration (where the total protein concentration is [X]tot, the critical
concentration is Kc ¼ c/a, and the supercritical concentration is Ks ¼ b/a; see text). Below the critical concentration, neither oligomers nor ﬁbrils are stable
relative to the monomer. Fibril formation therefore does not occur when [X]tot , Kc. Between the critical and supercritical concentrations, oligomers are less
stable than the monomer, the nucleus is the highest-energy species on the ﬁbril formation pathway, and ﬁbrils become stable relative to the monomer when they
are large enough. Above the supercritical concentration, both oligomers and ﬁbrils are stable relative to the monomer. Curve ii corresponds to the classical
picture of a nucleated polymerization. Note that the nucleus size is independent of the concentration.
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50-mer. For example, in helical ﬁbrils (7,12,41), the number
of interactions formed upon subunit addition changes when
the ﬁrst loop of the helix is closed (see Fig. 1 B). The nucleus
size for helical ﬁbrils is one less than the number of mono-
mers in a single loop of the helix (12), which is unlikely to be
large. Constant nucleus-size models have been used suc-
cessfully to describe ﬁbril formation by actin (33,34,42–46)
and ﬂagellin (47), both of which have small nuclei (three to
four monomer units). They have not been useful for ﬁbrils
with larger nuclei. For example, ﬁbril formation by hemo-
globin S, which has a nucleus size on the order of 20, had
to be modeled with a concentration-dependent nucleus size
(10,11).
The rate equations for our nucleated polymerization model
can be written using the information in Fig. 1 A. However,
we have found it convenient to rescale the time and con-
centration variables as suggested by Goldstein and Stryer (9):
t ¼ ct; xi ¼ ½Xi=Kc; f ¼ ½F=Kc; m ¼ ½M=Kc; (2)
where t is time. This rescaling results in time being measured
relative to the monomer-ﬁbril dissociation rate constant, and
the concentrations being measured relative to the critical
concentration. All of the rescaled variables are dimension-
less. The rate equations, mass balance, and initial conditions
for our nucleated polymerization model can be written in
terms of the rescaled variables as follows (see Supplemen-
tary Material):
dx1
dt
¼ x1 2x11 +
n
i¼2
xi
 
1s 2x21 +
n
i¼3
xi
 
 x1f 1 f ;
(3)
dxi
dt
¼ ðx1xi1  sxiÞ  ðx1xi  sxi1 1Þ; 2 # i # n 1;
(4)
dxn
dt
¼ ðx1xn1  sxnÞ  x1xn; (5)
df
dt
¼ x1xn; (6)
dm
dt
¼ ðn1 1Þx1xn1 x1f  f ; (7)
xtot ¼ +
n
i¼1
ixi1m; (8)
x1;t¼0 ¼ xtot; x2;t¼0 ¼ x3;t¼0 ¼    xn;t¼0 ¼ ft¼0 ¼ mt¼0 ¼ 0;
(9)
where s ¼ b/c ¼ Ks/Kc; s is the rescaled equivalent of the
supercritical concentration. Inspection of Eqs. 3–9 reveals
that they cannot reach steady state, since df/dt and dm/dt are
always .0. However, steady state can be most closely
approached when x1 ¼ 1 (i.e., [X1] ¼ Kc), xi ¼ 1/si1, and,
substituting these expressions into Eq. 8,
m ¼ xtot  +
n
i¼1
ixi ¼ xtot  +
n
i¼1
i=s
i1
(10)
(see Supplementary Material). Equations 3–9 are a good
model for ﬁbril formation reactions until this near steady-
state point is reached, but because f and m continue to
increase after this point, the approximation breaks down at
long times. We will therefore limit our use of Eqs. 3–9 to
before and just after this near-steady-state point. Rescaling
the time and concentration variables reduces the number of
parameters to three: s, xtot, and n. Ferrone has warned,
however, that rescaling can obscure whether a given value
for a parameter is physically reasonable (8). The parameter
ranges that will be used herein have been chosen to be
appropriate for amyloid ﬁbril formation: they are 102# s #
105, xtot # 10
6, and 3 # n # 9. These parameter ranges are
justiﬁed in the Supplementary Material.
Limiting cases
We examine two limiting cases here. The ﬁrst is that of a
classical nucleated polymerization. The features of a classi-
cal nucleated polymerization (in particular, the high con-
centration dependence of the rate) are well known and have
already been mentioned in the Introduction. We merely wish
to add here that classical nucleated polymerizations require
the following conditions to be met: 1), the monomer must
quickly come to a preequilibrium with oligomers, so that the
nucleation rate is dictated by the relative stabilities of the
nucleus and monomer; 2), the oligomer concentrations must
be low enough to be ignored relative to the monomer con-
centration (xi  xl, 2 # i # n); and 3), the initial monomer
concentration must be high enough for monomer dissocia-
tion from ﬁbrils to be negligible throughout most of the ﬁbril
formation reaction. The ﬁrst two conditions are met when xtot
 s and the third is met when 1 xtot, so this limiting case
obtains when 1  xtot  s. The rate equations (Eqs. 3–9)
can be simpliﬁed for a classical nucleated polymerization
and solved analytically (7) (see Supplementary Material).
We show the solutions for x1, f, and m here (since they will
be used later):
x1 ¼ xtot sech t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn1 1Þxn1 1tot
2s
n1
s0
@
1
A
2
4
3
5
2
n1 1
; (11)
f ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2x
n1 1
tot
ðn1 1Þsn1
s
tanh t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn1 1Þxn1 1tot
2s
n1
s0
@
1
A; (12)
m ¼ xtot 1 sech t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn1 1Þxn1 1tot
2s
n1
s0
@
1
A
2
4
3
5
2
n1 1
8><
>:
9>=
>;: (13)
Equation 13 allows the constant in Eq. 1 to be expressed in
terms of the parameters n and s. Monomer dissociation from
ﬁbrils is ignored in classical nucleated polymerizations
(because of the third condition listed above), so m ¼ xtot
at completion and therefore m ¼ 0.5xtot at t50. Inserting
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m¼ 0.5xtot into Eq. 13, solving for t50, inserting the solution
into Eq. 1, and converting from t50 and [X]tot to t50 and xtot
yields
log10t50 ¼ log10
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2s
n1
n1 1
s
sech
1ð0:5ðn1 1Þ=2Þ
2
4
3
5
 n1 1
2
 
log10xtot: (14)
Equation 14 shows that the value of t50 for a classical
nucleated polymerization can be determined at any value of
xtot if n and s are known.
Our second limiting case is that of very high concentra-
tions. Monomer dissociation from both ﬁbrils and oligomers
can be ignored when the protein concentration is high enough
(xtot  s) (9). Thus, this limiting case corresponds to an irre-
versible polymerization. The rate equations for an irreversible
polymerization can be solved analytically (see Supplementary
Material), yielding
xi ¼ xtotes s
i1
ði 1Þ!
s
i
i!
 
; i $ 1; (15)
where s is a concentration-time integral (48,49)
s ¼
Z t9
0
x1 dt: (16)
Goldstein and Stryer have also obtained Eq. 15 for the
special case i ¼ 1 (9). Solutions for xi in terms of t could in
principle be obtained by inverting Eq. 16, but this yields an
exponential integral:
t ¼ 1
xtot
Z s
0
e
s9
1 s9ds9: (17)
Equation 17 can only be integrated numerically, but in-
spection reveals that t/N as s/ 1, which implies that the
reaction is complete at s¼ 1. The concentration of the mono-
mer at this point, the end of the reaction, is 0, whereas the con-
centrations of the other species are:
xi;s¼1 ¼ xi;t/N ¼ xtote1i 1
i!
: (18)
Fig. 2 A is a plot of the weight fractions (ixi/xtot) of
monomers to hexamers over the course of an irreversible
polymerization. Fig. 2 B is a plot of weight fractions at the
end of an irreversible polymerization against aggregate size.
(Weight fractions are plotted instead of concentrations
because they are independent of xtot; see Eqs. 15 and 18).
Fig. 2 shows that species larger than hexamers are always
negligible (weight fraction,0.01 for all t for i. 6) and that
dimers, trimers, and (to a lesser extent) tetramers are the
dominant species at the end of an irreversible polymeriza-
tion. It should be noted that experimental ﬁbril formation
reactions can behave like irreversible polymerizations only
while the monomer concentration is high. Eventually, when
the monomer concentration is low enough and oligomer
concentrations are high enough, monomer dissociation will
no longer be negligible. The ﬁbril formation reaction will
then relax from the (oligomer-rich) state it is in when mono-
mer dissociation can no longer be ignored to the near-steady-
state point (where ﬁbrils dominate). The effect of ﬁbril
formation reactions obeying the kinetics of irreversible poly-
merizations early in their time courses does not manifest itself
in the distribution of products at the end of the reaction, but
in the concentration dependence of the ﬁbril formation rate.
This point will be discussed further below.
Concentration dependence of ﬁbril formation
reaction rates: a test case
Some insight into the behavior of nucleated polymerizations
can be gained by studying a representative test case.
Equations 3–9 were therefore solved numerically with n ¼ 6,
s ¼ 1000, and xtot varying from 100.25 to 106 in steps of
100.25. Fig. 3 A is a plot of the fraction completion, deﬁned as
the ﬁbril mass concentration at a given time divided by the
ﬁbril mass concentration at the near-steady-state point (given
FIGURE 2 (A) Time courses of the weight fractions of the monomer (X1),
dimer (X2), trimer (X3), tetramer (X4), pentamer (X5), and hexamer (X6) in an
irreversible polymerization. The plots were made using Eqs. 15 and 17. The
quantity txtot is used for the time variable because t is inversely proportional
to xtot (see Eq. 17), so using txtot for the independent variable enables the
weight fraction plots to be independent of xtot. (B) A plot of weight fraction
versus species size at the end of an irreversible polymerization.
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by Eq. 10), against t (on a logarithmic scale) for selected
values of xtot. Fig. 3 B is a log-log plot of the values of t50
from the numerical solutions versus xtot. Fig. 3 shows that the
concentration dependence of ﬁbril formation kinetics
changes as the concentration increases, as has also been
observed by Kodaka (39). Three concentration regimes (low,
medium, and high) can be identiﬁed based on the relative
values of the total protein concentration (xtot) and the
supercritical concentration (s). In the low-concentration
regime, where xtot is much less than s (xtot# 10
1.5), the time
courses in Fig. 3 A are evenly spaced and the t50 vs. xtot log-
log plot in Fig. 3 B is linear. In fact, these t50 values are very
close (within 0.1 log10 unit) to the solid line in Fig. 3 B,
which represents the t50 values expected for a classical
nucleated polymerization (the solid line was plotted using
Eq. 14). In the medium-concentration regime, where xtot
is closer to, but still less than, s (101.5, xtot# s ¼ 103), the
fraction completion plots become increasingly closely spaced
in Fig. 3 A and the t50 values deviate from the solid line in
Fig. 3 B (although they still fall on the dashed curve, the
origin of which is explained below). The curvature in the
log-log plot of t50 vs. xtot shows that the ﬁbril formation
reaction does not meet the requirements of classical nucle-
ated polymerizations in the medium-concentration regime.
In the high-concentration regime, where xtot. s, the fraction
completion plots in Fig. 3 A are almost identical, and t50 is
nearly independent of xtot when xtot $ 10
5 in Fig. 3 B (t50
changes by ,0.05 log units between xtot ¼ 105 and 106).
This behavior marks an even more serious departure from
classical nucleated polymerization.
The concentration dependence of ﬁbril formation for this
test case can be understood by using the information in Fig.
4. Fig. 4 is a comparison of the numerical solutions of Eqs.
3–9 to the solutions of a classical nucleated polymerization at
xtot¼ 10 (Fig. 4 A) or 100 (Fig. 4 B), or to the solutions of an
irreversible polymerization at xtot ¼ 105 (Fig. 4 C). The
values of xtot used in Fig. 4 represent the low, medium, and
high-concentration regimes. Three phases in the ﬁbril for-
mation reaction can be identiﬁed in the low and medium-
concentration regimes. In the ﬁrst phase (preequilibration),
the monomer quickly reaches preequilibrium with oligomers
and the nucleus. In the second phase (nucleation), nucleation
takes place at a constant nucleus concentration, and therefore
at a constant rate. In the third phase (conversion), monomer
is converted to ﬁbrils. The ﬁbril formation reaction ends
when the monomer concentration is equal to the critical
concentration (x1 ¼ 1), at which point the reaction is at the
near-steady-state point. There is, however, an important
difference between the ﬁbril formation time courses in the
low and medium-concentration regimes. In the low-concen-
tration regime, where the total protein concentration is well
below the supercritical concentration, the ﬁbril formation
reaction meets the requirements for a classical nucleated
polymerization: the monomer reaches preequilibrium almost
instantaneously (by t ¼ 102), the concentrations of
oligomers are low (,2% of xtot), and xtot  1 throughout
most of the reaction. This assertion is supported by the
similarity between the numerical solutions of Eqs. 3–9 (solid
curves) and the classical nucleated polymerization solutions
(dashed curves) in Fig. 4 A. These solutions deviate only
near the end of the conversion phase (and only because
monomer dissociation from ﬁbrils is not accounted for in
classical nucleated polymerizations). In contrast, substantial
amounts of oligomers form during the preequilibration phase
in the medium-concentration regime (.15% of the total
FIGURE 3 (A) Plots of the fraction completion versus rescaled time (t) on
a logarithmic scale for the test case with n ¼ 6, s ¼ 1000, and selected
values of xtot. The fraction completion is deﬁned as m/mﬁnal, where mﬁnal is
the value of m at the near-steady-state point (see Eq. 10). Fraction
completion was calculated using the numerical solutions of Eqs. 3–9. Each
curve is labeled with its corresponding value of xtot. As mentioned in the
text, the curves for xtot ¼ 105–106 are nearly identical to each other. (B) A
plot of the rescaled time required for a ﬁbril formation reaction to reach 50%
completion (t50) against the total protein concentration (xtot), with both
variables on a logarithmic scale for the test case with n ¼ 6 and s ¼ 1000.
The solid circles represent the t50 values obtained from the numerical
solutions of Eqs. 3–9, the solid line represents the t50 values expected for a
classical nucleated polymerization (Eq. 14), and the dashed curve represents
the t50 values expected for a classical nucleated polymerization after
correcting for oligomer formation (Eq. 21).
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amount of protein when xtot ¼ 100; see Fig. 4 B), where the
total protein concentration is closer to the supercritical
concentration. This degree of oligomer formation violates
the second requirement of classical nucleated polymeriza-
tions. It causes the monomer concentration to be,xtot during
the nucleation phase, which lowers the nucleus concentra-
tion, which in turn decreases the ﬁbril nucleation rate and
slows the ﬁbril formation reaction. This point is illustrated by
the deviation of the numerical solutions (solid curves) from
the classical nucleated polymerization solutions (dashed
curves) in Fig. 4 B, and by the deviation of t50 from the
theoretical line at xtot ¼ 100 in Fig. 3 B. This deviation
increases as xtot approaches s.
Although the ﬁbril formation reaction in the medium-
concentration regime does not meet the second condition for
classical nucleated polymerizations, preequilibrium between
the monomer and oligomeric protein is quickly attained,
which meets the ﬁrst, and xtot 1, which meets the third (see
Fig. 4 B). These observations suggest that ﬁbril formation in
the medium-concentration regime can still be understood
within the framework of classical nucleated polymerizations.
In particular, Eq. 14 can still be used to calculate t50 values
for ﬁbril formation if xtot is replaced with the concentration of
monomer that actually exists during the nucleation phase. The
actual monomer concentration can be determined by noting
that at preequilibrium xi ¼ xi1=si1 (see Supplementary
Material) and the ﬁbril mass concentration should be negli-
gible (m 0). The conservation of mass (Eq. 8) then becomes
xtot ¼ +
n
i¼1
ixi1m  +
n
i¼1
ixi ¼ +
n
i¼1
ix
i
1
s
i1 
x1s
2
ðx1  sÞ2
: (19)
The relevant root of Eq. 19 is
x1 ¼ sð2xtot1s 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4sxtot1s
2
p
Þ
2xtot
: (20)
Equation 20 is accurate to ,5% for n $ 4 and xtot # s.
The error is .10% only when n ¼ 3 and xtot . 0.97s. Note
FIGURE 4 (A) Plots of monomer, oligomeric protein, and ﬁbril mass concentrations versus rescaled time (t) on a logarithmic scale for the test case with n¼ 6
and s ¼ 1000 in the low-concentration regime (xtot ¼ 10; the oligomeric protein concentration is deﬁned as 2x21 3x3 1 . . .1 nxn). The solid lines represent
the time courses from the numerical solutions (NS) to the rate equations. The dashed lines represent the time courses expected for a classical nucleated
polymerization (CNP). The three phases of the ﬁbril formation reaction, preequilibration, nucleation, and conversion, are marked above the plots. (B) As in A,
except that the plots are for the medium-concentration regime (xtot ¼ 100). (C) Plots of monomer, oligomeric protein, and ﬁbril mass concentrations versus
rescaled time (t) on a logarithmic scale for the test case with n ¼ 6 and s ¼ 1000 in the high-concentration regime (xtot ¼ 105). The solid lines represent the
time courses from the numerical solutions (NS) to the rate equations. The dashed lines represent the time courses expected for an irreversible polymerization
(IP). (Inset) An expansion of the monomer concentration time course between 105 , t , 102.
Supercritical Concentration for Amyloid 127
Biophysical Journal 91(1) 122–132
that x1/ xtot at preequilibrium when xtot  s. Replacing
xtot in Eq. 14 with the expression on the right-hand side of
Eq. 20 yields
log10t50 ¼ log10
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2s
n1
n1 1
s
sech
1ð0:5ðn1 1Þ=2Þ
2
4
3
5
 n1 1
2
 
log10
sð2xtot1s 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4sxtot1s
2
p
Þ
2xtot
" #
:
(21)
Equation 21 is plotted as the dashed curve in Fig. 3 B. This
curve deviates from the numerically calculated t50 values by
,0.15 log units between xtot¼ 100.25 and 103. The closeness
of this ﬁt justiﬁes the assertion made above that the test case
still behaves like a classical nucleated polymerization in the
medium-concentration regime, except for the amount of
oligomers formed. The dashed curve in Fig. 3 B, however,
still deviates from the t50 values in the high-concentration
regime.
As in the medium-concentration regime, a large amount of
oligomeric protein quickly forms in the high-concentration
regime (.97% of the total by t ¼ 104 at xtot ¼ 105).
Furthermore, preequilibrium between monomer and oligo-
mers is never attained, as illustrated by the lack of a plateau
in the oligomer concentration in Fig. 4 C. These two
observations indicate that neither the ﬁrst nor the second
requirement for a classical nucleated polymerization is met
by ﬁbril formation reactions in the high-concentration
regime, and it is therefore unlikely that the classical nu-
cleated polymerization framework will be useful in under-
standing their behavior. In contrast, the coincidence of the
numerical solutions of the rate equations (solid curves) and
the irreversible polymerization solutions (dashed curves) in
Fig. 4 C shows that the irreversible polymerization model
accurately predicts ﬁbril formation kinetics until the mon-
omer concentration becomes small enough that dissociation
reactions are no longer negligible (t  104). This similarity
to an irreversible polymerization can be used to explain the
near-independence of t50 and xtot in the high-concentration
regime as follows.
Fibril formation reactions at high concentrations behave
initially like irreversible polymerizations because association
reactions dominate dissociation reactions (x1xi  sxi for all
i). However, the monomer concentration decreases as ﬁbril
formation proceeds, allowing monomer dissociation reac-
tions to become more and more signiﬁcant. Eventually the
association and dissociation rates balance. This point is
illustrated in the inset to Fig. 4 C, which shows that the
monomer concentration reaches a gently sloping plateau at
x1  1500, or 3s/2. It can be shown (see Supplementary
Material) that the same happens at higher concentrations
with the plateau always being close to 3s/2, no matter what
xtot is. When x1 reaches its plateau, the concentrations of
dimers, trimers, etc. are close to the concentrations expected
at the end of an irreversible polymerization (see Supple-
mentary Material). As a result, the concentrations of olig-
omers are directly proportional to xtot (see Eq. 18). Now, the
time required for the ﬁbril formation reaction to proceed
from the point at which x1 has reached its plateau to com-
pletion depends on the magnitudes of the individual terms in
the rate equations relative to the total amount of protein that
has to be converted into ﬁbrils. Almost all of the terms in
Eqs. 3–7 have the form x1xi or sxi. Since x1 is independent of
xtot once it reaches its plateau and xi is directly proportional
to xtot for all i $ 2, these terms are directly proportional to
xtot. In other words, the terms in the rate equations increase in
direct proportion to the amount of protein that has to be
converted into ﬁbrils. Therefore, in the high-concentration
regime, the time required to convert the protein into ﬁbrils
remains roughly constant as the protein concentration in-
creases. In fact, it can be shown that
t50  ln 0:5
 5s
2
 s1
n!
 
1 2 cosðp=nÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s 3s
2
 s1
n!
 q (22)
is a reasonable, if rough, approximation for the asymptotic
value of t50 at extremely high concentrations. Equation 22
is accurate to within a factor of ;4, depending on n and s
(see Supplementary Material). Note that the parameter n in
Eq. 22 does not represent the size of the thermodynamic
nucleus, since the monomer is the ‘‘nucleus’’ in the high-
concentration regime. Instead, n represents the size of the
structural nucleus, that is, the size of the species that would
be the nucleus if the protein concentration were less than the
supercritical concentration.
Our assumption that species grow only by monomer
addition, which is crucial to the results described above, may
not be physically realistic in the high-concentration regime.
Because oligomers are abundant during ﬁbril formation in
the high-concentration regime (Fig. 4 C), there is no reason
to expect that they will not associate with each other. If
oligomer-oligomer association occurred, the ﬁbril formation
reaction would have the same kinetics as colloidal aggrega-
tion, as ﬁrst described by von Smoluchowski (50,51). Fibril
formation models in which oligomer-oligomer associations
occur are beyond the scope of this work, but Kodaka has
shown that, under these circumstances, the rate of ﬁbril for-
mation would be inversely proportional to the total protein
concentration (39).
Concentration dependence of ﬁbril formation
rates for 3 # n # 9 and 102 # s # 105
Fig. 5 is composed of log-log plots of t50 against xtot for
several values of n and s. Each plot contains t50 values
calculated from the numerical solutions to the rate equations
for a range of total protein concentrations (xtot # 10
6), for
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four values of s (s ¼ 102, 103, 104, and 105) at a given value
of n (n ¼ 3, 6, or 9). The behavior observed in the test case
described above is evident in the plots in Fig. 5. The t50
values (solid circles) are close to the values expected for a
classical nucleated polymerization in the low-concentration
regime (xtot  s; solid lines). They deviate from classical
behavior in the medium-concentration regime (xtot, s), but
still are close to the values expected for a nucleated poly-
merization after correction for oligomer formation (dashed
curves). Finally, the t50 values deviate from both of these
approximations in the high-concentration regime (xtot . s),
becoming nearly constant at very high concentrations. It is
noteworthy that the fastest ﬁbril formation reactions occur
when both s and xtot are very large (compare the t50 values at
xtot ¼ 106 for the cases in which s ¼ 102 and 105 for any
nucleus size). This ﬁnding is, perhaps, counterintuitive,
because high values of s should result in low nucleus
concentrations and slow ﬁbril formation rates. However, fast
ﬁbril formation reactions require not only high nucleus con-
centrations, but also high monomer concentrations (because
the rate of ﬁbril nucleation is the product of the concentra-
tions of these two species, and the rate of ﬁbril elongation is
proportional to the monomer concentration). As shown in the
preceding section, the monomer concentration quickly
reaches a plateau value close to 3s/2 in the high-concentra-
tion regime. Larger values ofs therefore lead to higher mono-
mer concentrations and faster ﬁbril formation.
DISCUSSION
The kinetics of nucleated polymerizations
at high concentrations
Our results demonstrate that ﬁbril formation reactions with
the mechanism in Fig. 1 A, including amyloid ﬁbril
formation, behave differently as the total protein concentra-
tion changes relative to the supercritical concentration. This
difference in behavior manifests itself in log-log plots of t50
vs. xtot. These plots start as straight lines in the low-
concentration regime (protein concentration  supercritical
concentration), as expected from the classical picture of
nucleated polymerizations. The plots become curved in the
medium-concentration regime (protein concentration ,
supercritical concentration), and eventually become ﬂat lines
in the high-concentration regime (protein concentration .
supercritical concentration). These ﬁndings should be borne
in mind when interpreting experimental data from ﬁbril
formation reactions; the mechanism shown in Fig. 1 A should
not be dismissed only because log-log plots of experimental
t50 values versus total protein concentration are found to be
FIGURE 5 Log-log plots of the rescaled time required for a ﬁbril formation reaction to reach 50% completion (t50) against the total protein concentration
(xtot). Data for several values of n and s are shown. The solid circles represent the t50 values obtained from the numerical solutions of the rate equations, the
solid lines represent the t50 values expected from a classical nucleated polymerization (classical NP), and the dashed curves represent the t50 values expected
from a classical nucleated polymerization after correcting for oligomer formation (corrected NP). The colors of the solid circles, solid lines, and dashed curves
correspond to the values of s as shown in the key in the lower right, and each graph shows data for a single value of n. (A) n ¼ 3; (B) n ¼ 6; and (C) n ¼ 9.
Supercritical Concentration for Amyloid 129
Biophysical Journal 91(1) 122–132
curved. In fact, as discussed below, useful information can
be extracted from such data.
Connection to experiment
Log-log plots of t50 vs. xtot should be accurately described
by Eq. 14 when 1  xtot  s and by Eq. 21 when xtot is
closer to, but still less than, s. Relationships like those in
Eqs. 14 and 21 can be established for the experimentally
relevant unrescaled quantities, t50, [X]tot, and Ks:
log10t50 ¼ Q
n1 1
2
log10½Xtot for Kc  ½Xtot  Ks;
(23)
log10t50 ¼ Q
n1 1
2
3log10
Ksð2½Xtot1Ks 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4Ks½Xtot1K2s
q
Þ
2½Xtot
2
4
3
5;
for ½Xtot,Ks;
(24)
where Q is a constant. Fits of Eqs. 23 and 24 to log-log plots
of t50 vs. [X]tot can be used in principle to determine n and
possibly Ks, both of which are important for characterizing a
nucleated polymerization. Whether these parameters can be
accurately estimated in practice depends on the level of error
in the t50 measurements, the breadth of the concentration
range for which t50 values were experimentally measured,
and the location of this concentration range relative to the
supercritical concentration. We suggest the following guide-
lines for the use of Eq. 24: the standard error in the measured
t50 values should be ,0.3 log units (about a factor of 2); the
t50 values should be measured over at least a 30-fold con-
centration range; and the protein concentration should be close
enough to the supercritical concentration for there to be notice-
able curvature in the log-log plot of t50 vs. [X]tot. If the plot is
not curved, Eq. 23 instead of Eq. 24 should be ﬁt to the t50
data. Finally, if the plot is ﬂat (i.e., t50 is nearly independent
of [X]tot), then neither Eq. 23 nor Eq. 24 should be ﬁt to the
data.
Good ﬁts of Eqs. 23 and 24 to experimental t50 data that
yield physically reasonable estimates of n and Ks are
evidence that a ﬁbril formation reaction is a nucleated
polymerization, but independent tests are always desirable.
Examination of the time course of a ﬁbril formation reaction
can provide such a test. Ferrone has shown that the early
portion of nucleated polymerization time courses (the ﬁrst
10–20%) are well described by the expression
½M ¼ A½1 cosðBtÞ; (25)
where A and B are adjustable parameters (8,10,11,34). We
have found empirically that Eq. 25 ﬁts the ﬁrst 10% of the
time courses of nucleated polymerizations in all concentra-
tion regimes (data not shown). In contrast, Eq. 25 does not ﬁt
the time courses of ﬁbril formation reactions that have other
mechanisms (for example, those in which ﬁbril fragmenta-
tion or heterogeneous nucleation are important secondary
pathways for the formation of new ﬁbrils) (8,10,11,34).
Thus, if Eq. 25 ﬁts the time courses of the ﬁbril formation
reactions of a given protein and Eq. 23 or 24 ﬁts the log-log
plot of t50 vs. [X]tot, it can reasonably be concluded that the
protein forms ﬁbrils by a nucleated polymerization mecha-
nism and estimates obtained for n and/or Ks can be con-
sidered valid.
The effect of variable nucleus sizes
The ﬁndings described in the previous sections are most
relevant to ﬁbril formation reactions in which the nucleus size
is constant, but they also have some relevance to ﬁbril
formation reactions in which the nucleus size depends on
concentration. Aswe have argued above, in constant-nucleus-
size-models, oligomers become more stable as the concen-
tration increases, which causes log-log plots of t50 vs. xtot to
be curved. In variable-nucleus-size models, the nucleus size
will change in addition to oligomers becoming more stable as
the concentration increases. The curvature in log-log plots of
t50 vs. xtot for variable-nucleus-size models therefore should
be even more pronounced than it is for constant-nucleus-size
models. At very high concentrations, the nucleus ceases to be
the highest energy species on the ﬁbril formation pathway in
both types of models. Fibril formation reactions will initially
behave like irreversible polymerizations when the concentra-
tion is well above the supercritical concentration, and t50
values will be independent of the total protein concentration,
no matter what type of model is used for nucleation.
CONCLUSIONS
The behavior of a nucleated polymerization reaction depends
on concentration. When the protein concentration is low
relative to the supercritical concentration, the classical be-
havior described by Oosawa and Asakura is observed (7).
When the protein concentration is close to (but not greater
than) the supercritical concentration, the dependence of the
time required for the reaction on the protein concentration
weakens, but this can be corrected for simply by accounting
for the amount of monomer that forms oligomers during the
nucleation phase. The reaction retains the essential features
of a nucleated polymerization. However, when the protein
concentration is greater than the supercritical concentration,
the time required for the reaction becomes almost indepen-
dent of the protein concentration and the reaction resembles
an irreversible polymerization at early times. This drastic
change in behavior occurs because the monomer, not the
nucleus, is the highest-energy species on the ﬁbril formation
pathway. The different behavior of nucleated polymeriza-
tions at different protein concentrations must be borne in
mind when assigning mechanisms based on experimental
data.
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SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
We thank Jeffery W. Kelly and Joel N. Buxbaum for helpful discussions.
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